Clarius Group LLC’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,123
| Closed | -$291K | – | 486 |
|
|
2023
Q4 | $291K | Buy |
1,123
+60
| +6% | +$15.5K | 0.02% | 359 |
|
|
2023
Q3 | $273K | Sell |
1,063
-350
| -25% | -$90K | 0.03% | 361 |
|
|
2023
Q2 | $402K | Buy |
1,413
+112
| +9% | +$31.9K | 0.03% | 310 |
|
|
2023
Q1 | $362K | Sell |
1,301
-101
| -7% | -$28.1K | 0.03% | 329 |
|
|
2022
Q4 | $388K | Buy |
1,402
+26
| +2% | +$7.2K | 0.03% | 307 |
|
|
2022
Q3 | $367K | Buy |
1,376
+258
| +23% | +$68.8K | 0.04% | 287 |
|
|
2022
Q2 | $228K | Sell |
1,118
-191
| -15% | -$39K | 0.02% | 405 |
|
|
2022
Q1 | $314K | Hold |
1,309
| – | – | 0.02% | 348 |
|
|
2021
Q4 | $314K | Sell |
1,309
-253
| -16% | -$60.7K | 0.02% | 348 |
|
|
2021
Q3 | $442K | Buy |
1,562
+5
| +0.3% | +$1.42K | 0.04% | 240 |
|
|
2021
Q2 | $539K | Sell |
1,557
-21
| -1% | -$7.27K | 0.05% | 198 |
|
|
2021
Q1 | $441K | Buy |
1,578
+298
| +23% | +$83.3K | 0.04% | 216 |
|
|
2020
Q4 | $313K | Sell |
1,280
-45
| -3% | -$11K | 0.03% | 254 |
|
|
2020
Q3 | $376K | Sell |
1,325
-247
| -16% | -$70.1K | 0.05% | 181 |
|
|
2020
Q2 | $421K | Buy |
1,572
+283
| +22% | +$75.8K | 0.06% | 161 |
|
|
2020
Q1 | $408K | Buy |
1,289
+39
| +3% | +$12.3K | 0.08% | 131 |
|
|
2019
Q4 | $366K | Buy |
1,250
+135
| +12% | +$39.5K | 0.06% | 167 |
|
|
2019
Q3 | $260K | Buy |
1,115
+183
| +20% | +$42.7K | 0.05% | 217 |
|
|
2019
Q2 | $218K | Sell |
932
-156
| -14% | -$36.5K | 0.04% | 228 |
|
|
2019
Q1 | $257K | Buy |
+1,088
| New | +$257K | 0.06% | 163 |
|